Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Claud B who wrote (1023)	12/16/1997 7:12:00 PM
From: Dettmer	Respond to of 7041

ALTAREX CORP., immunotherapeutic biotech company. Comparable to CNTO, CYTO, MEDX, CLTR, IDPH, PDLI, IMMU. Conducting Phase IIb pivotal trial for its ovarian cancer therapeutic vaccine Ovarex in the US, and Phase II/III in Europe and Canada.

To: Claud B who wrote (1023)	12/16/1997 7:28:00 PM
From: Bill Wexler	Read Replies (2) \| Respond to of 7041

You should check his track record first. Mr. Asensio is generally reviled, particularly by Wall Street bottom-feeders who push garbage stocks on small investors, because he dares to expose scam companies for what they really are. He also profits from short-selling these companies. He is generally up-front about the fact that he takes short positions....unlike paid shills, who will hype a worthless stock and make every effort to hide the fact that they're being compensated by the company. BTW, Asensio is not a pure short-seller. He manages a fund that holds both long and short positions. He is a value investor with an excellent track record. As far as his reports concerning scams like Solv-ex and Zoangen: I find his research to be very high quality. I'm sure he has saved quite a few people from losing large amounts of money.